|
nab-paclitaxel combined with carboplatin Clinical Trials
1 actively recruiting trial
Also known as: paclitaxel combined with carboplatin
Pipeline
Phase 3: 1
Top Sponsors
- Women's Hospital School Of Medicine Zhejiang University1
Indications
- Primary Peritoneal Carcinoma Stage IV1
- Primary Peritoneal Carcinoma Stage III1
- Fallopian Tube Carcinoma Stage IV1
- Fallopian Tube Carcinoma Stage III1
- Epithelial Ovarian Carcinoma Stage IV1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.